ExRNA communication is a recently discovered cell-to-cell signaling process that holds enormous promise for improving our understanding of a wide variety of diseases. NCATS participates in the NIH Common Fund’s program to investigate this new scientific field. Learn more.
ExRNA Projects Target Biomarkers and Therapies
NCATS’ projects will test and validate extracellular RNA molecules as disease biomarkers and treatments.
Work with Us
A better understanding of basic exRNA biology could open doors to improving the diagnosis, prognosis and treatment of diseases and conditions such as cancer, bone marrow disorders, heart disease, Alzheimer's disease and multiple sclerosis.
Extracellular RNA Communication (ExRNA)
About ExRNA Communication
Get more information about the NIH Common Fund’s exRNA Communication program and NCATS’ participation.
ExRNA Communication Funding Information
Learn how NIH Institutes and Centers, including NCATS, administer exRNA support from the NIH Common Fund.
ExRNA Communication Projects
Find out more about the exRNA projects that NCATS administers through the NIH Common Fund.
The Promise of ExRNA
Scientists are only beginning to understand the potential that exRNA research may hold for improving diagnosis, prognosis and treatment of a wide range of diseases and conditions. But researchers need to know more about basic exRNA biology first.
To advance this new field of research and address a collective scientific need, NIH launched the Extracellular RNA Communication program in July 2012. NCATS is administering 18 of the program's first 30 awards. Learn more about the ExRNA Communication program.